IRIDEX Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IRIX research report →
About the company
IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions.
- CEO
- Patrick Mercer
- IPO
- 1996
- Employees
- 93
- HQ
- Mountain View, CA, US
Price Chart
- Market Cap
- $19.67M
- P/E
- -5.95
- P/S
- 0.37
- P/B
- 4.13
- EV/EBITDA
- -11.84
- Div Yield
- 0.00%
- Gross Margin
- 36.12%
- Op Margin
- -5.12%
- Net Margin
- -6.23%
- ROE
- -64.23%
- ROIC
- -16.95%
- Revenue
- $52.67M · 8.23%
- Net Income
- $-4,437,000 · 50.20%
- EPS
- $-0.26 · 51.85%
- Op Income
- $-2,571,000
- FCF YoY
- 69.06%
- 52W High
- $1.65
- 52W Low
- $0.87
- 50D MA
- $1.09
- 200D MA
- $1.15
- Beta
- 0.66
- Avg Volume
- 252.06K
Get TickerSpark's AI analysis on IRIX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 13, 26 | Dizon Romeo R | other | 2,691 |
| Jun 13, 26 | Mercer Patrick | other | 3,990 |
| Jun 12, 26 | Dizon Romeo R | buy | 975 |
| Jun 11, 26 | Dizon Romeo R | buy | 1,675 |
| Jun 8, 26 | Dizon Romeo R | buy | 2,400 |
| Jun 5, 26 | Dizon Romeo R | buy | 2,521 |
| Jun 3, 26 | Dizon Romeo R | buy | 2,400 |
| May 26, 26 | Mercer Patrick | other | 19,233 |
| May 26, 26 | Dizon Romeo R | buy | 5,004 |
| Apr 1, 26 | Novel Inspiration International Co., Ltd. | other | 87,949 |
Our IRIX coverage
Recent articles, reports, and earnings notes.
No research on IRIX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IRIX report →Similar companies
Peers in the same neighborhood.